Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/23/16 → 03/15/21 |
Funding
- PPD Investigator Services LLC: $73,865.44
PFIZER: A Phase 3, Multinational, Randomized, Open-Label, Parallel-Arm Study of Avelumab (MSB 0010718C) Combination with Axitinib vs.Sunitinib Monotherapy in the First-Line Treatment of Patients with Advanced Renal Cell Carcinoma
- Keresztes, Roger (CoPI)
- Zhang, Yue (CoI)
- Zhang, Yue (PI)
- Kudelka, Andrzej (CoPI)
Project: Research